Cardinal Health Inc  

(Public, NYSE:CAH)   Watch this stock  
Find more results for CAH
+1.91 (2.30%)
Jul 31 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 83.16 - 85.20
52 week 68.54 - 91.91
Open 83.32
Vol / Avg. 4.52M/2.93M
Mkt cap 28.11B
P/E 24.81
Div/yield 0.39/1.82
EPS 3.42
Shares 330.83M
Beta 0.58
Inst. own 88%
Oct 28, 2015
Q1 2016 Cardinal Health Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Sep 16, 2015
Cardinal Health Inc at Morgan Stanley Healthcare Conference - 8:45AM EDT - Add to calendar
Sep 10, 2015
Cardinal Health Inc at Robert W Baird and Co Health Care Conference - 7:50AM EDT - Add to calendar
Sep 9, 2015
Cardinal Health Inc at FBR Healthcare Conference - 12:00PM EDT - Add to calendar
Jul 30, 2015
Q4 2015 Cardinal Health Inc Earnings Release
Jul 30, 2015
Q4 2015 Cardinal Health Inc Earnings Call
Jun 10, 2015
Cardinal Health Inc at Goldman Sachs Healthcare Conference
Jun 5, 2015
Cardinal Health Inc Dublin Day
May 13, 2015
Cardinal Health Inc at Bank of America Merrill Lynch Health Care Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 1.44% 1.28%
Operating margin 2.33% 2.07%
EBITD margin - 2.81%
Return on average assets 5.31% 4.49%
Return on average equity 23.48% 18.79%
Employees 34,000 -
CDP Score - 75 E


7000 Cardinal Pl
DUBLIN, OH 43017-1091
United States - Map
+1-614-7573033 (Phone)
+1-614-7576000 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


Cardinal Health, Inc. is a healthcare services company providing pharmaceutical and medical products and services that help pharmacies, hospitals and other healthcare providers focus on patient care. The Company reports its financial results in two segments: Pharmaceutical and Medical. In the United States, the Pharmaceutical segment, distributes branded and generic pharmaceutical, over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers (including chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers), hospitals and other healthcare providers. The Medical segment distributes a range of medical, surgical and laboratory products to hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers in the United States, Canada and China and to patients in the home in the United States.

Officers and directors

George S. Barrett Chairman of the Board, Chief Executive Officer
Age: 59
Bio & Compensation  - Reuters
Michael C. Kaufmann Chief Financial Officer
Age: 51
Bio & Compensation  - Reuters
Donald M. Casey Jr. Chief Executive Officer - Medical Segment
Age: 54
Bio & Compensation  - Reuters
Jon Giacomin Chief Executive Officer - Pharmaceutical segment
Bio & Compensation  - Reuters
Carole S. Watkins Chief Human Resource Officer
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Stephen T. Falk Executive Vice President, General Counsel, Corporate Secretary
Age: 49
Bio & Compensation  - Reuters
Mark R. Blake Executive Vice President - Strategy and Corporate Development
Age: 43
Bio & Compensation  - Reuters
Craig S. Morford Chief Legal and Compliance Officer
Age: 55
Bio & Compensation  - Reuters
Patricia A. Hemingway Hall Director
Age: 55
Bio & Compensation  - Reuters
David John Anderson Independent Director
Age: 65
Bio & Compensation  - Reuters